VITALITY BIOPHARMA INC
SACRAMENTO, CA--(Marketwired - Feb 4, 2015) - Stevia First Corp. (
Event: SeeThruEquity Winter MicroCap Investor Conference
Location: Convene in Times Square (810 7th Avenue, New York, NY 10019)
Date: Thursday, February 5, 2015
Time: 10:30 AM ET
Mr. Robert Brooke, CEO of SF Corp., will be discussing the Company's business operations and growth strategy during the presentation and conducting one-on-one meetings with investors.
To arrange a one-on-one meeting with management, please contact Andrew Haag at stvf@irthcommunications.com or 1-866-976-4784.
About SeeThruEquity
SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The research is not paid for and is unbiased. SeeThruEquity does not conduct any investment banking or commission based business. SeeThruEquity is approved to contribute its research to Thomson Reuters One (First Call), CapitalIQ, FactSet, and Zacks and distribute its research to its database of opt-in investors. SeeThruEquity also contributes its estimates to Thomson Estimates, one of the leading estimates platform on Wall Street. SeeThruEquity was formed in March 2011. Since then, it has initiated coverage on numerous NYSE, NASDAQ, TSX, and OTC companies in a variety of industries including technology, health care, consumer, energy and special situations. It has hosted several investor conferences in New York City.
About Stevia First Corp. (
SF Corp. is an agricultural biotechnology company that is enabling dramatically healthier food and nutrition products. For more information visit: www.steviafirst.com and connect with the Company on Twitter, LinkedIn, Facebook and Google+.
About the Stevia Industry
The market for all-natural, zero-calorie stevia sweeteners is expanding rapidly. The World Health Organization (WHO) estimates stevia intake could eventually replace 20-30% of all dietary sweeteners. The total global sweetener market was estimated at $58.3 billion in 2010. For more information visit: www.steviafirst.com.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, projections of worldwide sales of stevia products, growth of stevia production and global markets. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
